Evolent Health, Inc.
General ticker "EVH" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $681.1M (TTM average)
Evolent Health, Inc. does not follow the US Stock Market performance with the rate: -27.7%.
Estimated limits based on current volatility of 3.1%: low 4.59$, high 4.88$
Factors to consider:
- Total employees count: 4500 as of 2024
- Top business risk factors: Labor/talent shortage/retention, Acquisition/divestiture risks, Stock price volatility affecting recruitment, Regulatory and compliance, Strategic risks and growth management
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.63$, 7.51$]
- 2026-12-31 to 2027-12-31 estimated range: [3.14$, 8.15$]
Financial Metrics affecting the EVH estimates:
- Positive: with PPE of 45.1 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Positive: 6.59 < Operating cash flow per share per price, % of 8.39
- Positive: Investing cash flow per share per price, % of -0.05 > -0.60
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: 19.24 < Shareholder equity ratio, % of 21.86 <= 42.59
Short-term EVH quotes
Long-term EVH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,955.79MM | $2,535.82MM | $1,890.42MM |
| Operating Expenses | $2,027.00MM | $2,576.30MM | $2,300.56MM |
| Operating Income | $-71.21MM | $-40.48MM | $-410.14MM |
| Non-Operating Income | $-131.19MM | $-22.55MM | $-124.50MM |
| Interest Expense | $54.20MM | $24.72MM | $57.47MM |
| Income(Loss) | $-202.41MM | $-63.04MM | $-534.64MM |
| Taxes | $-89.36MM | $-1.41MM | $-0.13MM |
| Net Income(Loss)* | $-113.04MM | $-61.62MM | $-534.51MM |
| Stockholders Equity | $1,067.70MM | $1,001.26MM | $415.19MM |
| Assets | $2,680.31MM | $2,544.41MM | $1,899.24MM |
| Operating Cash Flow | $142.58MM | $18.77MM | $38.84MM |
| Capital expenditure | $28.75MM | $24.89MM | $34.09MM |
| Investing Cash Flow | $-415.54MM | $-62.93MM | $-0.23MM |
| Financing Cash Flow | $281.34MM | $-0.56MM | $-35.92MM |
| Earnings Per Share** | $-1.02 | $-0.54 | $-4.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.